“The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children” has been published in Pharmaceutical Medicine. Clinical trial scientists and their teams, for several decades, have partially succeeded in improving ways on how paediatric trials are conducted. In 2007, the European Union recognised the need to facilitate development of medicines…
Details“Path towards efficient paediatric formulation development based on partnering with clinical pharmacologists and clinicians, a c4c expert group White paper” has been published by British Journal of Clinical Pharmacology. Despite regulatory requirements and incentives, paediatric formulations still lag behind adult formulations for medicines used in both adults and children. This is largely due to…
DetailsRelated posts: How c4c is improving European paediatric clinical research through partnerships European research networks to facilitate drug research in children Improving clinical paediatric research using lessons learnt from COVID-19 Health Technology Assessment of Paediatric Medicines
DetailsWhat is conect4children? [Video] Better medicines for babies, children and young people Thanks to the joint forces of both academic and industry partners, the Pan-European network, c4c aims to accelerate the development of innovative medicines for the entire paediatric population. c4c listens to the voices of children, young people, and their families, and is committed…
DetailsRelated posts: What are patients’ needs and how to improve the development of medicines? Meet the project leadership team! What are the c4c National Hubs (NHs)? Patient and Public Involvement (PPI)
Details
